C12Y 301/06008
Cerebroside-sulfatase
Official title: Cerebroside-sulfatase (3.1.6.8)
C12Y301/06008 (Cerebroside-sulfatase) appears on 32 US grants and 48 published applications in this corpus.
Search patents in C12Y- Granted patents
- 32
- Published applications
- 48
- Assignees
- 16
- Inventors
- 62
- Latest grant
- 9 Sep 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2005 | 0 | 1 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 1 | 1 |
| 2009 | 0 | 2 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 2 |
| 2013 | 2 | 3 |
| 2014 | 3 | 6 |
| 2015 | 3 | 3 |
| 2016 | 0 | 2 |
| 2017 | 3 | 4 |
| 2018 | 2 | 3 |
| 2019 | 2 | 3 |
| 2020 | 2 | 5 |
| 2021 | 3 | 0 |
| 2022 | 4 | 2 |
| 2023 | 0 | 5 |
| 2024 | 4 | 2 |
| 2025 | 3 | 4 |
By publication year.
Recent patents
- CNS delivery of therapeutic agents9 Sep 2025US 12,409,210 B2Takeda Pharmaceutical Company Limited
- Mutated arylsulfatase a9 Sep 2025US 12,410,415 B2Rheinische Friedrich-Wilhelms-Universität Bonn
- Methods for purification of arylsulfatase A3 Jun 2025US 12,319,940 B2Takeda Pharmaceutical Company Limited
- Methods and compositions for CNS delivery of arylsulfatase A17 Dec 2024US 12,168,041 B2Takeda Pharmaceutical Company Limited
- Methods and compositions for CNS delivery of heparan N-sulfatase10 Dec 2024US 12,161,702 B2Takeda Pharmaceutical Company Limited
- Cns delivery of therapeutic agents11 Dec 2025US 2025/0375506 A1Takeda Pharmaceutical Company Limited
- Paper-based analytical device for potentiometric enzyme detection11 Dec 2025US 2025/0376712 A1
- Methods and compositions for cns delivery of arylsulfatase a22 May 2025US 2025/0161417 A1Takeda Pharmaceutical Company Limited
- Methods and compositions for cns delivery of iduronate-2-sulfatase17 Apr 2025US 2025/0121040 A1Takeda Pharmaceutical Company Limited
- Methods for purification of arylsulfatase a28 Nov 2024US 2024/0392268 A1Takeda Pharmaceutical Company Limited
Most cited
By later US patents
- Delivery of therapeutic compounds to the brain and other tissues90US 7,442,372 B2Biomarin Pharmaceutical Inc. · 2008
- Methods and compositions for increasing arylsulfatase A activity in the CNS19US 8,715,661 B2ArmaGen Technologies, Inc. · 2014
- Methods and compositions for increasing arylsulfatase A activity in the CNS17US 8,920,801 B2ArmaGen Technologies, Inc. · 2014
- Methods and compositions for increasing arylsulfatase A activity in the CNS13US 8,486,399 B2ArmaGen Technologies, Inc. · 2013
- Methods and compositions for CNS delivery of iduronate-2-sulfatase13US 9,220,677 B2Shire Human Genetic Therapies, Inc. · 2015